Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole

Authors

  • Mohamed A. Hassan Metwally Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
  • Rubina Ali Oncology Department, Nuclear Medicine, Oncology & Radiotherapy Institute, Islamabad, Pakistan
  • Maire Kuddu Radiation Oncology Center, North Estonia Medical Center, Tallinn, Estonia
  • Tarek Shouman Radiation Oncology Department, National Cancer Institute, Cairo, Egypt
  • Primoz Strojan Department of Radiation Oncology, Institute of Oncology, Ljubljana, Slovenia
  • Jens Overgaard Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
  • Cai Grau Department of Oncology, Aarhus University Hospital, Denmark

DOI:

https://doi.org/10.3109/0284186X.2015.1074721

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2015-10-21

How to Cite

Hassan Metwally, M. A., Ali, R., Kuddu, M., Shouman, T., Strojan, P., Overgaard, J., & Grau, C. (2015). Radiotherapy quality assurance of the IAEA-HypoX trial of the accelerated radiotherapy in the treatment of head and neck squamous cell carcinoma with or without the hypoxic radiosensitizer nimorazole. Acta Oncologica, 54(9), 1673–1677. https://doi.org/10.3109/0284186X.2015.1074721

Issue

Vol. 54 No. 9 (2015): Acta Oncologica

Section

Articles